bibliographic entry 12595358 [be/12595358]
https://w3id.org/oc/corpus/be/12595358

is a
content
  • Richman, SD, Seymour, MT, Chambers, P. KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial, J Clin Oncol, 2009, 27, 5931, 5937, PMID: 19884549
references